Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

Genica Network, Annegien Broeks, Marjanka K Schmidt, Mark E Sherman, Fergus J Couch, John L Hopper, Gillian S Dite, Carmel Apicella, Letitia D Smith, Fleur Hammet, Melissa C Southey, Laura J Van 't Veer, Renate de Groot, Vincent T H B M Smit, Peter A Fasching, Matthias W Beckmann, Sebastian Jud, Arif B Ekici, Arndt Hartmann, Alexander HeinRuediger Schulz-Wendtland, Barbara Burwinkel, Frederik Marme, Andreas Schneeweiss, Hans-Peter Sinn, Christof Sohn, Sandrine Tchatchou, Stig E Bojesen, Børge G Nordestgaard, Henrik Flyger, David D Ørsted, Diljit Kaur-Knudsen, Roger L Milne, Jose I Arias Pérez, Pilar Zamora, Primitiva Menéndez Rodríguez, Javier Benítez, Hiltrud Brauch, Christina Justenhoven, Yon-Dschun Ko, Ute Hamann, Hans-Peter Fischer, Thomas Brüning, Beate Pesch, Jenny Chang-Claude, Shan Wang-Gohrke, Michael Bremer, Johann H Karstens, Peter Hillemanns, Thilo Dörk, Jonine Figueroa

Research output: Contribution to journalArticlepeer-review

Abstract

Breast cancers demonstrate substantial biological, clinical and etiological heterogeneity. We investigated breast cancer risk associations of eight susceptibility loci identified in GWAS and two putative susceptibility loci in candidate genes in relation to specific breast tumor subtypes. Subtypes were defined by five markers (ER, PR, HER2, CK5/6, EGFR) and other pathological and clinical features. Analyses included up to 30 040 invasive breast cancer cases and 53 692 controls from 31 studies within the Breast Cancer Association Consortium. We confirmed previous reports of stronger associations with ER+ than ER- tumors for six of the eight loci identified in GWAS: rs2981582 (10q26) (P-heterogeneity = 6.1 × 10(-18)), rs3803662 (16q12) (P = 3.7 × 10(-5)), rs13281615 (8q24) (P = 0.002), rs13387042 (2q35) (P = 0.006), rs4973768 (3p24) (P = 0.003) and rs6504950 (17q23) (P = 0.002). The two candidate loci, CASP8 (rs1045485, rs17468277) and TGFB1 (rs1982073), were most strongly related with the risk of PR negative tumors (P = 5.1 × 10(-6) and P = 4.1 × 10(-4), respectively), as previously suggested. Four of the eight loci identified in GWAS were associated with triple negative tumors (P ≤ 0.016): rs3803662 (16q12), rs889312 (5q11), rs3817198 (11p15) and rs13387042 (2q35); however, only two of them (16q12 and 2q35) were associated with tumors with the core basal phenotype (P ≤ 0.002). These analyses are consistent with different biological origins of breast cancers, and indicate that tumor stratification might help in the identification and characterization of novel risk factors for breast cancer subtypes. This may eventually result in further improvements in prevention, early detection and treatment.

Original languageEnglish
Pages (from-to)3289-303
Number of pages15
JournalHuman Molecular Genetics
Volume20
Issue number16
DOIs
Publication statusPublished - 15 Aug 2011

Keywords

  • Asian Continental Ancestry Group
  • Biomarkers, Tumor
  • Breast Neoplasms
  • European Continental Ancestry Group
  • Female
  • Genetic Loci
  • Genetic Predisposition to Disease
  • Humans
  • Odds Ratio
  • Penetrance
  • Receptor, ErbB-2
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Risk Factors

Fingerprint

Dive into the research topics of 'Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium'. Together they form a unique fingerprint.

Cite this